Literature DB >> 2460992

Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C.

M G Mateu1, J L Da Silva, E Rocha, D L De Brum, A Alonso, L Enjuanes, E Domingo, H Barahona.   

Abstract

The antigenic behavior of 46 field isolates of foot-and-mouth disease virus (FMDV) of serotype C has been studied with a panel of 24 monoclonal antibodies (MAbs) prepared against FMDV C1 or FMDV C3 Indaial. Reactivities were assayed by immunodot, immunoelectrotransfer blot, and neutralization of infectivity. The epitopes recognized by the 10 nonneutralizing MAbs are conserved in all isolates analyzed. In contrast, extreme antigenic heterogeneity is documented with regard to reactivity with 14 MAbs that, on this basis, define at least 12 epitopes involved in neutralization of FMDV of serotype C. The 31 isolates from South America were divided into 17 distinct antigenic groups and the 15 isolates from Europe into 7 groups. Lack of correspondence between antigenic composition and the origin--date and place of isolation--of the viruses was noted in several instances. Antigenic heterogeneity is shown among epidemiologically closely related FMDVs. In most--but not all--cases tested, a good correlation was found between binding of a neutralizing MAb to virions and its ability to neutralize infectivity. It is concluded that variation of epitopes involved in neutralization of FMDV is extensive among subtypes of serotype C and also among individual isolates of one subtype.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460992     DOI: 10.1016/0042-6822(88)90060-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies.

Authors:  M A Martínez; C Carrillo; F González-Candelas; A Moya; E Domingo; F Sobrino
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 3.  Molecular evolution of aphthoviruses.

Authors:  E Domingo; M G Mateu; C Escarmís; E Martínez-Salas; D Andreu; E Giralt; N Verdaguer; I Fita
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

Review 4.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

5.  Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.

Authors:  T R Doel; C Gale; C M Do Amaral; G Mulcahy; R Dimarchi
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  The foot and mouth disease virus type O outbreak of 1992 is not related to vaccine strain (O/R2/75).

Authors:  V Suryanarayana; P Tulasiram; K S Prabhudas; L D Misra; C Natarajan
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

7.  A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.

Authors:  O Taboga; C Tami; E Carrillo; J I Núñez; A Rodríguez; J C Saíz; E Blanco; M L Valero; X Roig; J A Camarero; D Andreu; M G Mateu; E Giralt; E Domingo; F Sobrino; E L Palma
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA.

Authors:  Eric Baranowski; Nicolás Molina; José Ignacio Núñez; Francisco Sobrino; Margarita Sáiz
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.

Authors:  Teresa Rodríguez-Calvo; Samuel Ojosnegros; Marta Sanz-Ramos; Juan García-Arriaza; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.